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Ob]ectiws, This study was designed to define clinical and 
the c similarltles and differcnres between patients 
th I nd idiopathic dilated cardiomyopathy. 
Buckgreurrd. Significant coronary artery disease in patients 
with new onset congestive heart failure due to dilated cardiomy. 
apathy has important prognostlc and therapeutic implications, 
Methods, Chical, bistologk, ventriculographic and hemody- 
namic features of patients with dilated cardiomyopathy who 
underwent coronary angiography were reviewed. 
, Patients wltk ischemic cardiomyopathy (n = 21) 
co with those with idiopathic cardiomyopathy (n = 40) had 
similar presenting symptoms, durations of illness, and coronary 
factor profiles, with the exception of a greater prevalence of 
tte smoking (71% vs. 39%, p = 0.028) and male gender 
(100% vs. 70%, p = 0.014). Endomyocardial biopsy specimens 
hrn patients with ischemic cardiomyopathy demonstrated a 
greater prevalence of replacement fibrosis (48% vs. 8%, p = 
O&M) and a lesser degree of histologically assessed myocyte 
hypertrophy (mean grade 0.5 * 0.7 vs. 1.3 f 1,3, p = 0.015). 
Global eft ventricular dysfunction due to coronary artery 
disease was first described by Raftery et al. (1) in 1969 and 
subsequen~y termed ischemic ardiomyopathy by Burch et 
al. (2,3) in 1970. Early series described patients with a 
history of multiple prior myocardial infarcts and extensive 
coronary artery disease (4,5). Patients with ischemic cardio- 
myopathy have been shown to have a worse prognosis than 
patients with idiopathic dilated cardiomyopathy with similar 
clinical presentations and durations of illness (6,7). 
The development of a dilated cardiomyopathy after a 
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Although ventriculographically detc~m 
was present in both groups, there was a er preva~em~e of two 
or more adjacent segments in the isehemic cardiomyopathy group 
(50% vs. 10%) p = 0.03). This iscbemic group had hem~y~amic 
variables associated with a worse prognosis: higRer 
artery wedge pressure (23 9 10 vs. 15 4 9 mm Ng, p = 0. 
lower cardiac index (2.0 f 0.5 vs. 2.3 f 0.5 lite 
p = 0.044). Also, in this group, patients had a mean of 2.6 f 0.7 
diseased vessels: 15 (71%) of 21 patients had le.vessel disease 
and 18 (86%) of 21 bad at least one occlu or subo~clwded 
artery. 
Conclusions. 1) Patients with ischemic and idiopathic ca 
myopathy may be clinically indistinguishable unless co 
angiography is performed. 2) A greater prevalence of replacement 
fibrosis and a lesser degree of myocardial hypertropby in patients 
with ischemic card’ athy may 
of hemodyaamic d nsatior 0 
(J Am CON Cardiol1992;20:1318-25) 
myocardial infarction relates to both the size of the infarct 
(8) and abnormalities in remaining myocytes and microvas- 
culature (9-11). Infarct expansion (12) and myocardial re- 
modeling (13) lead to cavity dilation and increased wall 
stress. Increased volume and pressure loads on viable myo- 
cardium cause myocyte hypertrophy, a process that may be 
fwlly compensatory in small but inadequate in larger infarcts 
(14,151. The extent towhich myocyte hypt?rtrophy observed 
in human cardiomyopathies r presents a pathologic or com- 
pensatory process remains controversial. 
Studies (16,17) showing a poor relation between the 
amount of myocardial damage assessed at autopsy and the 
degree of premortem cardiac dysfunction have shed doubt 
on the notion that poorly functioning myocardium in patients 
with coronary artery disease represents fibrosis. The con- 
cept of chronically dysfunctional yet potentially viable isch- 
emit myocardium has been termed hibernating myocardium 
(18). 
Noncontrolled trials of coronary bypass urgery (19-21) 
and angioplasty (22) in patients with a poor ejection fraction 
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Figure 1. Outline of patienl selection protocol (see text). LVEDD = 
left ventricular end-diastolic dimension; MUGA-EF = multiple- 
gated acquisition (radionuclide ven~ricu~o~rap~~y) ejeclion fraction. 
have demonstrated improvement i  survival, symptoms and
ventricular function. However, both the Veterans Adminis- 
tration Cooperative Study (23) and the Coronary Artery 
Surgery Study (CASS) (20) have suggested that ac ive isch- 
emia may be a prerequisite o a survival advantage in
patients with diminished left ventricular function. 
trast, two recent studies (242.5) have reported similar sur- 
vival rates for selected patients with ischemic cardiomyop- 
athy who underwent r vascularization c mpared with those 
undergcing cardiac transplantation. It is therefore crucial to 
identify patients with left ventricular dysfunction due to 
ischemia s opposed to other origins of dilated cardiomyop- 
athy. 
The goals of this study were to delineate clinical charac- 
teristics distinguishing patients with ischemic cardiomyopa- 
thy and to identify factors responsible for the poor prognosis 
associated with this disease. We reviewed the records of a 
large group of patients with cardiomyopathy and congestive 
heart failure of new onset who underwent a thorough diag- 
nostic evaluation that included endomyocardial biopsy, right 
heart catheterization, ventriculography and coronary angi- 
graphy. 
atient selection. Th election criteria re out- 
lined in Figure 1. J3etween December 1982 and September 
1989, the cardiomyopathy service at The Johns Hopkins 
Hospital studied 450 patients with endomyocardial biopsy 
and right heart hemodynamic assessment for heart failure of 
new onset. A subset of 136 patients (30%) also underwent 
left heart catheterization t  rule out coronary artery disease. 
The indications for angiography included a history sugges- 
’ : of myocardial ischemia or cardiovascular risk factors: 
(26). ~Q~~~vas~ve assessme 
Of the remaining 108 patients, 21 ha
y causes of cardiomyopathy and were exclude 
r?Wia for exclusion. atients with structural or infiltra- 
tive heart diseases, with illnesses known to cause left 
ventricular dysfunction (endocrine, rbe~mat~c, connective 
tissue or renal) or with e 
and toxins were exclud 
coronary artery bypass su 
aneurysm (n = 2), poor 
years’ duration (n = 
significant aortic val 
disease (n = I), bi 
amyloidosis (n = 2), 
sclerosis (n = l), sa 
2), severe alcohol or cocaine abuse (n = lo), ad~amycin 
exposure (n = I), lithium toxicity (n = I), peripartum state 
(n = 2) and chronic renal failure (n = 3). 
The diagnostic critetia used for the classification f sec- 
ondary cardiomyopathies have been described in detail 
(Kasper et al., manuscript in preparation). In the present 
study, patients were considered tohave valvular or 
tensive cardiomyopathies only if they were free of co 
artery disease. patients who had had coronary bypass ur- 
gery were excluded because of the independent, positive or 
negative, effects of surgery, as were patientr. with left 
ventricular neurysm, who by definition do not nave dilated 
cardiomyopathy (26). Patients with chronic renal failure 
were excluded regardless ofthe presence of coronary artery 
disease because of the independent i fluences ofuremia on 
ntricular function (26). 
psy and sight heart ~~t~ete~~~~ti~n. Endomyocardial 
biopsy was performed with a Stanford-Caves bioptome with 
patients in a postabsorptive state without premeditation. 
Biopsies were performed preferentially with use of a self- 
sealing venous sheath introduced into the right internal 
jugular vein. Two percent of procedures used a femoral 
approach. In addition, 55 (90%) of 61 study patients under- 
went right heart catheterization f r determination f cardiac 
output and pressures in the right atrial, right ventricular, 
ary artery and pulmonary artery wedge positions. 
ology. Four to six right ventricular 
ens were obtained from each patient. 
was sectioned into two to four pieces and fixed in 10% 
formalin. Four hematoxylin-eosin-stained slides were exam- 
ined from each specimen. The following criteria were graded 
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Figure 2, A, Replacement fibrosis in an endomyocardial biopsy 
specimen from a patient with ischamic cardiomyopathy. Note 
the irregular shaped focus of myocyte dropout associated with 
fibrosis and hemosiderin-laden macrophage accumulation (arrow). 
I), Higher magnification demonstration of hemosiderin-laden mac- 
rophagcs in the focus of replacement fibrosis (arrows). Hema.toxy- 
lin-eosin x250 (A) and x630 @I, both reduced by 28%. 
on a scale from 0 (not present) to 4 (marked): replacement 
fibrosis, interstitial fibrosis and myocyte hypertrophy. 
Replacement fibrosis (Fig. 2A) was defined as a focus of 
myocyte dropout associated with fibrosis containing hemo- 
side&-laden macrophages (Fig. 2B). The myocytes at the 
edges of those lesions howed vacuolar degeneration and 
nuclear hypertrophy. Myocyte hypertrophy (Fig. 3) was 
defined by the presence of nuclear enlargement, hyperchro- 
masia and pleomorphism. Interstitial fibrosis (Fig. 4) was 
characterized by increased interstitial connective tissue 
without myocyte dropout or macrophage accumulation. 
Each biopsy specimen was subdivided into one of the five 
grades (0 to 4) on the basis of similarities among members of
each grade. Each grade did not necessarily contain equal 
numbers of cases. 
Histoloeic studies were read independently b two pa- 
thologists; disagreement on histologic grade was settled by 
Figure 3. Myocyte hypertrophy in an endomyocardial biopsy spec- 
imen from a patient with ischemic cardiomyopathy. Note the 
nuclear enlargement and hyperchromasia typical of hypertrophy. 
Hematoxylin-eosin x300, reduced by 28%. 
consensus. Interobserver reliability was assessed by com- 
pxing reader’s initial scores: 87% of scores were within one 
grade of each other, and there was 98% concordance on 
judging the presence or absence of replacement fibrosis. 
Coronary angiogra~hy. All patients as a requirement for 
entry into the study underwent coronary angiography. Cor- 
onary angiography and ventriculography were performed at 
The Johns Hopkins Hospital in routine, clinical fashion using 
a standard imaging system (GE Flouricon 300) on g-in. 
(22.9 cm) magnification at 30 frames/s on 35mm film (Agfa 
A). All coronary a~8iograms were reviewed by 
two investigators and read by consensus. Significant coro- 
nary artery disease was considered to be present in an artery 
if a stenosis of ~50% was noted. Stenoscs occurring proxi- 
Figure 4. Interstitial fibrosis in an endomyocardial biopsy specimen 
from a patient with ischemic cardiomyopathy. In contrast to the 
findings in replacement fibrosis, the myocytes are preserved and the 
interstitium contains an increased amount of connective tissue. 
Hematoxylin-eosin x280, reduced by 28%. 
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opacification) were av 
10 to 12 ml/s for a total of 50 to 75 ml. The ve~tric~~ogram 
was obtained after coronary a~g~ogra~by in all but five of the 
patients 
Analysis was done without knowle 
clinical status, history or coronary anatomy. Films were 
mounted on a standard projector (Vanguard X-35) and 
reviewed for quality and the presence of mitral regurgitation. 
The first end-diastolic frame to show full opac~ficat~o~ durin
regular rhythm, the subsequent end-systolic frame and tb 
frame showing the calibration grid (I cm) or ball (2.5 cm) 
were chosen for analysis. Each frame was il~ul~i~ate 
the aperture of a CCD video camera (Sony), whi 
attached to he projector by a side arm 
was digitized into a 488 x 388 matrix wi 
(Datacube IVG 128) and displayed o
analog color monitor (Sony Trinitron C 
‘The software (Computer Vision Research) was run on an AT 
compatible computer ;NCR Tower, 8 MHz) with an 80287 
math coprocessor. 
The diastolic and systolic right anterior oblique left ven- 
tricular contours w:re traced on the interactive monitor 
display with the use of a mouse and were superimposed 
on one another without realignment (27). The calibration 
factor was entered and results were obtained for global 
ejection fraction and left ventricul end-diastolic, end- 
systolic and stroke volume (28). gional wall motion 
(29) was assessed by the centerline method in which a 
midline is generated between end-diastolic and end-systolic 
contours, and 100 equally spaced cords are constructed 
perpendicular to this line. The length of each cord is normal- 
ized to the length of the end-diastolic contour perimeter to 
adjust for heart size. The mean chord motion was deter- 
mined for each of five regions: anterobasal, nterolateral, 
apical, diaphragmatic and posterobasal (29). Regions with 
negative mean chord motion were considered to be dyski- 
netic. 
Statistical analysis. Data are presented as a mean value + 
SD. Comparisons of continuous variables between groups 
utilized the Student I test. Histologic grades were compared 
with the Mann-Whitney rank-sum test. Comparison ofpro- 
portions were p rformed by using 95% confidence intervals 
and a chi-squared calculation orthe Fisher exact est where 
appropriate. Statistical calculations were performed by using 
Systat s~ftwar~~ 
Clinical presentation. The clinical features of patients 
with ischemic and idiopathic cardiomyopathy are outlined in 
. Chid Features of Patients 
idiopathic lschemic 
Cardiomyopathy Cardiomyopathy 
Patients tn0.t 40 21 
Age tyrt 49.7 % 11 s3.g i- 10 
Male/female ratic* ?t(il? (70/30) 2110 (10010) 
Duration of symptoms (months) 12.3 L 17 22.4 + 38 
Presenting symptoms 
Patients (no.) 39 21 
Congestive heart failure 33 (85) 20 (95) 
Ventricular arrhythmias 16 (41) 8 (38) 
Atrial fibrillation 7 (18) 3 (14) 
Conduction disturbance I (31 0 (0) 
Chest pain !tl(26) 4 (19) 
Medications 
Patients (no.) 34 ?I 
Digitalis 24 (79) 14 (67) 
Diuretics 26 (77) I5 (91) 
Afterload reducers I? (56) 10 (48) 
Nitratcs II (24) 7 (33) 
Ucta-adrenergic blocking agents 0 (0) I (5) 
Calcium channel antagonists 6 (18) 3 (14) 
Antiarrhythmic agents I.5 (44) 8 (38) 
Coronary risk factors 
Patients (no.) 36 21 
Drabetes 4(ll) 5 (24) 
Hypertension 10 (211) 3 (14) 
Smokingt 14 (39) 15 (71) 
Cholesterol 3 (81 3 (14) 
Family history I2 (33) 7 (33) 
Past history 
Patients (no.) 39 21 
Chest pain 4 (IO) 4 (19) 
Myocardial infarction 3 (8) 6 (29) 
Myocardial infarction, documented 0 tot 2 (IO) 
Values are expressed as mean value + SD or number CR) of patients 
within category in subgroup. *p = 0.014. tp = 0.028. All other differences are 
not statistically signilieanl. 
Table I. A total of 70% of patients with idiopati,ic ardio- 
myopathy were men comqared with 100% of those with 
ischemic ardiomyopathy (p = 0.014). The duration of 
symptoms in the two groups was similar; 76% and 70% of 
patients with idiopathic and ischemic cardiomyopathy, re- 
spectively, had symptoms for <I2 months. Both groups had 
a similar proportion of patients presenting with congestive 
symptoms, ventricular nd atrial arrhythmias nd chest pain. 
Only 19% of patients with ischemic ardiomyopathy ad 
symptoms compatible with angina pcctoris. 
At presentation, patients in both groups had received 
similar medical regimens, which included igitalis and di- 
uretic drugs in the majority and afterload-reducing agents in 
or was cigarette smokin 
prevalent in patients with tschemic than in those with 
idiopathic ardiomyopathy (71% vs. 39%, p = 0.028). Of 
patients in the ischemic group, only 19% had a past history 
of angina pectoris and 29% a past history of possible 
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Table 2. Endomvocardial Bionsv Histolonic Findinns 
Idiopathic Cardiomyopathy (II = 40) lschemic Cardiomvooathv (n = 21) 
Patients with finding 
Replacement fibrosis 
Interstiti,. ,iortisis 
Myocyte hypertrophy 
Histologic grade* 
Replacement fibrosis 
inierstitiai fibrosis 
Myocyte hypertrophy 
n CW 95% Cl -----_ 
3 (8) I to 22 
20 (51) 32 to 69 
34 (87) 69 to 96 
0.1 2 0.5 
’ I.6 I I.0 
1.3 + 1.3 
n (95’0) 95% Cl p Value 
-__-I---- 
10 (48) 22 to 72 0.001 
11 (52) 26 to 76 NS 
IS (71) 43 to 90 NS 
I.1 c I.2 Osltll 
0.6 1 0.5 NS 
0.5 2 0.7 0.015 
*Histologic grades are reported as mean value r SD. Cl = confidence interval. 
myocardial infarction. In the idiopathic group, 10% of pa- 
tients had a history of angina and 8% a history of possible 
myocardial infarction. Only two patients, both in the isch- 
emit group, had a myocardial infarction documented by an 
increase in creatine kinase. There was a trend toward a 
greater proportion of patients with ischemic cardiomyopathy 
giving a history of suspected myocardial infarction (p = 
0.054). 
istology. Morphologic findings were compared initially 
for prevalence and, if present in similar proportions in both 
groups, for severity (Table 2). In the ischemic cardiomyop 
athy group, 48% (95% confidence interval 22% to 72%) of 
patients had replacement fibrosis compared with 8% (95% 
confidence interval 1% to 22%) of patients with idiopathic 
cardiomyopathy (p = 0.001). This finding was 48% sensitive 
and 92% specific for ischemic cardiomyopathy. Both the 
positive and negative predictive values were 77%. Similar 
proportions of both groups had interstitial fibrosis and myo- 
cyte hypertrophy. However, the degree of myocyte hyper- 
trophy was greater in patients with idiopathic disease than in 
Table 3. Coronary Anatomy in Patients With 
Ischemic Cardiomyopathy 
Coronary Artery 
Left main 
Left anterior descending coronary 
Proximal occlusions 
DisWbranch occlusions 
Left circumflex 
Proximal occlusions 
Distal/branch occlusions 
Right coronary 
Proximal occlusions 
Distahbranch occlusions 
Number of vessels involved 
One 
Two 
Three 
At least one occluded or suboccluded artery 
Proximal 
Distal branch 
n (570) 
3 (14) 
21 (100) 
5 (24) 
2 (IO) 
19 (90) 
2 (IO) 
5 (24) 
I5 (71) 
5 (24) 
5 (24) 
2 (10) 
4 (19) 
I5 (71) 
I8 (86) 
14 (66) 
4 (191 
those with ischemic cardiomyopathy (mean grade I .3 ? I .3 
vs. 0.5 s 0.7, p = 0.015). 
C~r~~~~y anatomy and rej,jioual le ven~~i~M~a~ ~ nc~io~. 
Patients were initially classified as having ischemic cardio- 
myopathy if at least one major epicardial coronary artery 
contained a ~50% stenosis. However, patients with isch- 
emit cardiomyopathy proved to have a significantly greater 
degree of coronary artery disease (Table 3). The mean 
number of vessels involved was 2.6 + 0.7. All 21 patients 
had left anterior descending artery disease, five with a 
proximal occlusion. Fifteen patients (71%) had disease in- 
volving all three major epicardial arteries, and I8 (86%) had 
at least one artery with an occlusion or 99% stenosis. Both 
patients with single-vessel disease had a proximal left ante- 
rior descending artery stenosis. Of patients with idiopathic 
cardiomyopathy, only 4 of 40 had coronary artery disease, 
all with a ~50% stenosis in distal arteries or arterial 
branches. 
Regional wall motion abnormalities were assessed ven- 
triculographically in I2 patients with ischemic cardiomyop- 
athy and 20 with idiopathic cardiomyopathy (Table 4). Seven 
of I2 patients in the ischemic group had at least one 
dyskineiic segment compared with 8 of 20 patients with 
idiopathic cardiomyopathy (p = NS). Although the presence 
of a single dyskinetic segment did not distinguish ischemic 
from nonischemic cardiomyopathy, two or more adjacent 
dyskinetic segments had a higher prevalence in the ischemic 
group (50% vs. IO%, p = 0.03). 
Table 4. Regional Wall Motion Abnormalities in the Two 
Patient Groups 
ldiopa iic lschcmic 
Cardiomyopathy Cardiomyopathy 
Patients studied (no.) 20 I2 
Dyskinetic segments (no.) 
One 6 I 
Two 2 3* 
Three 0 3* 
Any 8 71 
*p = 0.03 for two or more dyskinetic segments. +p < 0.31 for any 
dyskinetic segment. 
diopathic lschemic 
Patients fno.) 
Ejection fraction (%) 
End-diastolic volume (ml) 
Resures (mm Hg) 
Right atrial 
Right ventricular sysiolic 
Right ventricular diastolic 
Pulmonary artrry sys~oi~c 
Pulmonary artery diastolic 
Pulmonary arterial wedge 
Systemic systolic 
Systemic diastolic 
Heart rate (beatslmin) 
Curdiac index (liten/min per tn’, 
Systemic VXiCUlilr resistance index 
(dynes.s-cm -’ per m’) 
Pulmonary vascular resistance index 
tdynes.s,cm ’ per m?) 
Left ventricular stroke work index (g-m/m’) 
Right ventricular stroke work index (g-m/m’) 
36 
282 I2 
20s + 47 
187 -‘- 167 
292 II 
R%4 
724 
51 + 16 
10 i- 5 
ji + 16 
24 -+ 9 
23 * 10 
116 ? IS 
78 2 9 
93 2 13 
2.0 + 0.5 
3.416 + 976 
432 .z 208 
21 r7 
923 
NS 
0.009 
0.025 
G.WB 
0.001 
0.006 
0.013 
NS 
NS 
0.044 
NS 
0.008 
0.m 
NS 
Values are reported as mean value T SD or number of patients. 
Ventricular dyskinetic segments in patients with ischemic 
cardiomyopathy related to the presence of proximal coro- 
nary artery occlusions. All seven patients with a dyskinetic 
ventricular segment had at least one proximally occluded 
artery (p = O.OOl), which was the left anterior descending 
artery in five. The three patients with ree adjacent dyski- 
netic segments had at least wo occluded or subocc!aded 
proximal coronary arteries. Of the five patients with isch- 
emit cardiomyopathy who did not have dyskinetic seg- 
ments, four had an arterial occlusion or subocclusion ir, 
distal or branch arteries. 
The following anatomic findings in patients with schemic 
cardiomyopathy were examined for an association with the 
presence of replacement fibrosis on endomyocardial b opsy: 
a left anterior descending artery stenosis before the first 
septal perforator branch, an occluded or suboccluded vessel, 
three-vessel disease and the presence and extent of ventric- 
ular dyskinesia. None of these findings prored to have a 
statistically significant association. 
Global left ventricular function and hemodynamics. Left 
ventricular ejection fraction and end-diastolic volumes were 
similar in patients with ischemic and idiopathic cardiomyop- 
athy (Table 5). However, cardiac ndex (2.0 +0.5 vs. 2.3 f 
0.5 literslmin per m2, p = 0.044) and calculated left ventric- 
ular stroke work index (21 -C 7 vs. 29 -I II g-m/m2, p = 
6) were lower in patients wit iic car Y. 
Right ventricular, pulmonary artery and pulmonary artery 
wedge pressures were higher in patients with ischemic 
cardiomyopathy (Table 5). Right atrial filling pressure and 
systemic vascular esistance index were similar in both 
groups. 
The initial published f “ischemic ardiomy- 
opathy” emphasized t sentation of patients 
with congestive heart failure (l-3). Subsequent series con- 
tained patients with docu ented previous myocardial infarc- 
tion (4,5). Evidence has accumulated supporting the exist- 
ence of ischemic ventricular dysfunction that is reversible 
(I$), and recent studies (24,25) suggest that patients with 
ischemic ardiomyopathy may benefit from revasculariza- 
tion, altering their other poor prognosis (Q,7). The goals 
of this study were to co are and contrast theclinical and 
pathophysiologic featu patients with ischemic and 
idiopathic cardiomyopat 
Clinical findings in kc 
y. The clinical pre ns of patients in 
were similar regardless of etiology of cardiomyopathy. The 
most common presentation was that of heart failure. The 
Framingham Study (30) showed that 23% of myocardial 
infarctions were clinically unrecognized and that 12% of 
patients with such infarction presented with symptonls of 
congestive heart failure. th cardiomyopathy groups con- 
tained aminority of patie with a prior history of chest pain 
or myocardial infarction. xplanations for the pathophysiol- 
atients with dilate 
phied dilated ventricles and possible abnormalities in both 
vasodilator and vasoconstrictor coronary artery regulation 
(3 I). The only risk factor that was more prevalent inpatients 
with ischemic versus idiopathic cardiomyopathy was smok- 
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ing. Cigarette smoking has been shown to be a risk factor for 
the deveiopment of diffuse and regional ventricular dysfunc- 
tion in patients with and without coronary artery disease (32) 
and a cause of silent ischemia in patients with angina 
pectoris (33). Cigarette smoking may therefore be important 
in the pathogenesis of both ischemic and nonischemic car- 
diomyopathy. Thus, it may not be possible to predict by 
history or risk factors for coronary artery disease the pres- 
ence of ischemic ardiomyopathy in patients with heart 
failure of new onset and dilated cardiomyopathy. 
emodynamic fir:lings in patients with isrhemic versus 
idiopathic cardiomyopathy. Patients with ischemic ardio- 
myopathy had  greater degree of hemodynamic decompen- 
sation compared with those with idiopathic cardiomyopathy. 
Previous studies have documented the poorer prognosis 
associated with ischemic cardiomyopathy. Franciosa et al. 
(6) reported a 69% as compared with a 48% 2-year mortality 
rate for ischemic and idiopathic ardiomyopathy, respec- 
tively. In the latter study, left ventricular filling pressure: 
correlated with survival. Likoff et al. (7), in a study of 201 
patients with New York Heart Association functional class 
II or III heart failure showed that ischemic cardiomyopathy 
was an independent predictor of mortality. 
Histologic findings in ischemic versus idiopathic cardiomy- 
opathy. Myocyfe ~~JxwTJ~~~. No prior study of ischemic 
cardiomyopathy in humans has correlated histologic findings 
with ventriculographic findings, coronary anatomy and he- 
modynamics. In this study, we show two major histologic 
differences between patient groups with ischemic versus 
idiopathic cardiomyopathy. First, myocyte hypertrophy oc- 
curs to a lesser degree in patients in the ischemic group. 
Hypertrophy ofviable myocytes after an infarction i itially 
causes compensation f rboth pressure and volume overload 
and may normalize wall stress (IO). However, hypertrophic 
myocytes may become dysfunctional in the presence of 
ongoing pressure and volume overload (14.15). The finding 
of less myocyte hypertrophy inpatients with ischemic car- 
diomyopathy who have poorer hemodynamic indexes ug 
gests that he hypertrophy is inadequate, 
Replacement fibrosis. The second important histologic 
difference between ischemic and idiopathic cardiomyopathy 
was the greater prevalence in the former of replacement 
fibrosis. Such fibrosis could represent the edge of a larger 
fibrotic region or could arise from microvascular disease. 
Anversa et al. (11) observed an inadequate d gree of capil- 
lary proliferation i  rats with large infarcts and elevated left 
ventricular filling pressures. Replacement fibrosis has been 
observed in the cardiomyopathy of systemic sclerosis (34) 
and may be due to a Raynaud’s-like phenomenon ccurring 
in the coronary microvasculature. Endothelium inpatients 
with coronary artery disease has n abnormal vasocoostric- 
tor response to acetylcholine (35) and elaborates d creased 
mounts of nitric oxide (endothelium-derived r laxation 
factor) (36). These abnormalities may lead to microvascular 
spasm and myocyte necrosis. 
Severity of coronary artery disease i 
emit versus idiopathic cardiomyopathy. In our review of 108 
patients with dilated cardiomyopathy, patients with i chemic 
cardiomyopathy were clearly distinguishable from idiopathic 
patients by severe coronary artery disease. The majority of 
patients had multiple v ssel involvement, proximal stenoses 
and coronary occlusions. The presence of one or mc:re 
proximal coronary occlusions was associated with large 
ventricular dyskinetic segments. Yatteau et al. (4) found that 
98% of 66 patients with ischemic cardiomyopathy had dou- 
ble- or triple-vessel disease and Dash et al. (5) noted that 
cardiomyopathy was related to proximal stenoses. More 
recently, experimcrrtal ilnd cli ica8 studies (37) have sug- 
gested that patients with occluded infarct-related arteries 
have more severe degrees of infarct expansion and myocar- 
dial remodeling, processes important in the pathogencsis of 
ischemic ardiomyopathy (12,13). As such, WC believe that 
the presence of a single 250% coronary stenosis may not 
sufficiently define “ischemic cardiomyopathy.” In this 
study, the majority of patients with ischemic ardiomyopa- 
thy had severe reduction i  coronary blood flow to large or 
multiple territories and at least one occluded coronary 
artery. Further study will be required to assess the impor- 
tance c; less severe coronary artery stt noses in patients with 
dilated cardiomyopathy. 
Diagnosis of ischemic cardiomyopathy. Clinical detection 
of these patients was made possible by endomyocardial 
biopsies, which demonstrated r placement fibrosis withmy- 
ocyte hypertrophy of a lesser degree than that of patients 
with idiopathic cardiomyopathy. Large dyskinetic segments 
and severe hemodynamic decompensation were suggestive 
but not diagnostic of ischemic ardiomyopathy. Coronary 
arteriography remains the standard diagnostic modality and 
is obviously essential if surgical or catheterization revascu- 
larization is to be considered. 
Limitaibls of tke study. This study failed to address 
several important issues regarding ischemic ardiomyopa- 
thy. First, it was biased toward patients with risk factor 
profiles or symptoms suggestive of coronary artery disease 
and failed to address the true prevalence and incidence of 
coronary artery disease in patients with cardiomyopathy. 
Second, it did not assess whether patients who presented 
with congestive heart failure due to ischemic ardiomyopa- 
thy had reversible ventricular dysfunction. Finally, mortality 
data were not available, preventing the confirmation of 
decreased survival in patients with ischemic cardiomyopa- 
thy. 
Conclusions. In this study, we have shown that patients 
with ischemic ardiomyopathy cannot be distinguished from 
those with idiopathic cardiomyopathy by clinical features. 
Coronary angiography is recommended forpatients without 
a defined etiology for their dilated cardiomyopathy or for 
those in whom an endomyocardial biopsy demonstrates 
replacement fibrosis. The observed higher prevalence of 
replacement fibrosis and lesser degree of myocyte hypertro- 
phy in patients with ischemic as compared with idiopathic 
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